The intro of the most recent femtosecond laser beam, the VICTUS system, by these two market leaders further validates the field of laser beam cataract surgery. Related StoriesILUVIEN continues showing excellent results in EuropeAlimera Sciences announces outcomes from ongoing research on ILUVIENSaint Louis University ophthalmologist gives ideas to manage night eyesight issuesBausch + Lomb and TPV are dealing with regulatory authorities all over the world to protected advertising approvals for the brand new platform and, as announced previously, will promote the machine globally, leveraging their mixed cataract and refractive experience and commercial features. Our concentrate is on getting innovative products, just like the VICTUS system, to advertise that uniquely advantage ophthalmic surgeons and individuals, stated Robert E.Because pneumonia affects sufferers with COPD and frequently causes exacerbations disproportionately, the Centers for Disease Control currently recommend that all adults with COPD have the 23-valent pneumococcal polysaccharide vaccination . Nevertheless, the efficacy of PPSV23 isn’t more developed in the COPD individual population. Reasonable effectiveness for this vaccine offers been demonstrated in cohort research in adults with lung disease, said Tag Dransfield, M.D. Of the University of Alabama at Birmingham and lead author of the study. [However,] debate remains about its efficiency and immunogenicity in COPD. Dr. Colleagues and Dransfield sought to look for the efficacy of a more recent type of vaccine, PCV7, a proteins conjugate vaccine, which attaches a fragile antigen to a more powerful antigen in the wish that the stronger antigen with provoke a more forceful defense from the disease fighting capability.